DERACE L. SCHAFFER, M.D.

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

Altimmune, Inc.

Filing Date Source Excerpt
2010-05-24 Dr. Schaffer was chosen to serve as a director of the Company because of his substantial experience as an executive, board member and investor in the healthcare and technology industries and his practical experience in the medical field.
2011-11-07 Dr. Schaffer was chosen to serve as a director of the Company because of his substantial experience as an executive, board member and investor in the healthcare and technology industries and his practical experience in the medical field.
2012-04-30 Dr. Schaffer is a medical doctor and founder of a venture capital firm specializing in healthcare and high technology investments.
2013-04-30 Dr. Schaffer was chosen to serve as a director of the Company because of his substantial experience as an executive, board member and investor in the healthcare and technology industries and his practical experience in the medical field.
2014-05-08 Dr. Schaffer was chosen to serve as a Director of the Company because of his substantial experience as an executive, Board member and investor in the healthcare and technology industries and his practical experience in the medical field.
2015-04-30 Dr. Schaffer was chosen to serve as a director of the Company because of his substantial experience as an executive, Board member and investor in the healthcare and technology industries and his practical experience in the medical field.
2016-04-29 Dr. Schaffer was chosen to serve as a director of the Company because of his substantial experience as an executive, Board member and investor in the healthcare and technology industries and his practical experience in the medical field.
2017-09-01 Dr. Schaffer received his postgraduate radiology training at Harvard Medical School and Massachusetts General Hospital, where he served as Chief Resident.

Data sourced from SEC filings. Last updated: 2026-03-05